Orphenadrine Citrate
Product Images NDC 52959-527

1 FDA label image from H.j. Harkins Company, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Orphenadrine Citrate (NDC 52959-527). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by H.j. Harkins Company, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (100 mg Tablet Bottle Label)

Principal Display Panel (100 mg Tablet Bottle Label)
Orphenadrine Citrate 100 mg extended-release tablets label showing NDC 52959-527. The label includes manufacturer details (H.J. Harkins Company, Inc., repackaged by GLOBAL P.), lot number OC158GX, expiration date 06/09, and a note to take as directed by a doctor. It references the product 'Norflex' for comparison and identifies the tablet as a white round tablet.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.